How long for cialis to peak

Determining the earliest time within 30 minutes to erectogenic effect after tadalafil 10 and 20 mg: a multicenter, randomized, double-blind, placebo-controlled, at-home study.
Introduction: Tadalafil is a phosphodiesterase 5 (PDE5) inhibitor used for the treatment of erectile dysfunction (ED). The minimal time to onset of erectogenic effect in the at-home setting has not been evaluated.
Aim: The goal was to determine the earliest time to erectogenic effect leading to successful intercourse within 30 minutes after taking tadalafil 10 and 20 mg.
Methods: The multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase-2 study enrolled men at least 21 years old with a minimum 3-month history of ED. Four single doses each of placebo, tadalafil 10 mg, or 20 mg were taken at home once every 8-10 days. Using a stopwatch, couples recorded in Sexual Encounter Profile diaries the earliest time within 30 minutes after dosing to the first erection adequate for vaginal penetration, and whether the erection led to successful intercourse.
Main outcome measures: The primary analysis compared the percentage of erections resulting in successful intercourse between tadalafil groups and placebo at one-minute intervals using a step-down procedure. A secondary analysis compared the overall distribution of time to erectogenic effect between treatment groups using the Cox Regression Method.
Results: Compared to placebo, a significant erectogenic response to tadalafil 20 mg was found from 30 minutes down to 16 minutes after dosing (P = 0.012). Response to tadalafil 10 mg approached significance (P = 0.054) at 30 minutes. As analysed by the Cox Regression Method, a significant erectogenic response was found from 30 minutes down to 15 minutes after dosing for tadalafil 20 mg (P = 0.020), and from 30 minutes down to 26 minutes for tadalafil 10 mg (P = 0.042). Fifty-two percent of men taking tadalafil 20 mg had at least one successful intercourse attempt within 30 minutes compared to 35.1% of men taking placebo (P = 0.038).
Conclusions: This stopwatch-based study demonstrated a pharmacodynamic effect within 30 minutes after dosing for tadalafil 10 and 20 mg.
Similar articles.
Montorsi F, Padma-Nathan H, Buvat J, Schwaibold H, Beneke M, Ulbrich E, Bandel TJ, Porst H; Vardenafil Study Group. Montorsi F, et al. J Sex Med. 2004 Sep;1(2):168-78. doi: 10.1111/j.1743-6109.2004.04025.x. J Sex Med. 2004. PMID: 16422971 Clinical Trial.
Eardley I, Gentile V, Austoni E, Hackett G, Lembo D, Wang C, Beardsworth A. Eardley I, et al. BJU Int. 2004 Oct;94(6):871-7. doi: 10.1111/j.1464-410X.2004.05049.x. BJU Int. 2004. PMID: 15476525 Clinical Trial.
Porst H, Giuliano F, Glina S, Ralph D, Casabé AR, Elion-Mboussa A, Shen W, Whitaker JS. Porst H, et al. Eur Urol. 2006 Aug;50(2):351-9. doi: 10.1016/j.eururo.2006.02.052. Epub 2006 Mar 20. Eur Urol. 2006. PMID: 16766116 Clinical Trial.
Curran M, Keating G. Curran M, et al. Drugs. 2003;63(20):2203-12; discussion 2213-4. doi: 10.2165/00003495-200363200-00004. Drugs. 2003. PMID: 14498756 Review.
Rosenberg MT, Miner MM, Barnes AL, Janning SW. Rosenberg MT, et al. Int J Impot Res. 2011 Jan-Feb;23(1):9-16. doi: 10.1038/ijir.2010.30. Epub 2010 Dec 23. Int J Impot Res. 2011. PMID: 21179109 Review.
Cited by.
Jiang H, Zhao LM, Lin HC, Yan S, Liu JH, Zhu ZH, Luo JD, Dai YT, Li FB, Lou Y, Zhang ZC. Jiang H, et al. Asian J Androl. 2018 Nov-Dec;20(6):587-592. doi: 10.4103/aja.aja_47_18. Asian J Androl. 2018. PMID: 30004039 Free PMC article. Clinical Trial.
Evans JD, Hill SR. Evans JD, et al. Patient Prefer Adherence. 2015 Aug 12;9:1159-64. doi: 10.2147/PPA.S56002. eCollection 2015. Patient Prefer Adherence. 2015. PMID: 26316720 Free PMC article. Review.
Sung HH, Lee SW. Sung HH, et al. Korean J Urol. 2012 Jun;53(6):377-85. doi: 10.4111/kju.2012.53.6.377. Epub 2012 Jun 19. Korean J Urol. 2012. PMID: 22741044 Free PMC article.
Washington SL 3rd, Shindel AW. Washington SL 3rd, et al. Drug Des Devel Ther. 2010 Sep 7;4:159-71. doi: 10.2147/dddt.s9067. Drug Des Devel Ther. 2010. PMID: 20856843 Free PMC article. Review.
Vardi Y. Vardi Y. Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S420-2. doi: 10.2337/dc09-S351. Diabetes Care. 2009. PMID: 19875592 Free PMC article. Review. No abstract available.